Latest Industry Insights
Industry Insight
Waters’ Highly Flexible SYNAPT XS Offers Freedom of Analytical Choice
A highly flexible and high-resolution mass spectrometer, the SYNAPT™ XS technology from Waters has been developed with the analytical needs of R&D labs in mind. Joanne Ballantyne tells us more about the development of SYNAPT™ XS and the features to which it lends its versatility.
Industry Insight
Wellness and Illness From a Precision Quantification Perspective
In this interview, Aaron Hudson, Vice President & General Manager, Global Marketing & Strategy at SCIEX, discusses why precision quantification, specifically quantitative mass spectrometry (MS), is the best approach for measuring the transition from "wellness" to illness.
Industry Insight
BioAccord LC-MS: Making Mass Spectrometry Available to the Masses
Earlier in 2019, Waters Corporation announced their BioAccord LC-MS System for biopharmaceutical analysis. We spoke with John Gebler, PhD, Director of Strategic Business Development at Waters Corporation to learn more about the BioAccord System and its applications.
Industry Insight
Colorectal Cancer Blood Test Driven by Immuno-transcriptomics
By studying gene expression modifications induced by the immune response, Novigenix has developed a blood test for colorectal cancer. This Q&A with Jan Groen, CEO, provides insights on the test, and on the field of study that could revolutionize cancer diagnosis.
Industry Insight
ASMS Introduces… An Overview of What’s New for 2019
The 67th American Society for Mass Spectrometry (ASMS) Conference on Mass Spectrometry and Allied Topics is currently in full swing in Atlanta, Georgia. Bringing together over 6,500 scientists from across the globe, companies working in the mass spectrometry field also take this opportunity to share their latest developments and innovations. Here we will take a look at some of the release highlights for 2019.
Industry Insight
Why Should Antibodies Be Manufactured Recombinantly?
Given that bad antibodies are likely to blame for a significant proportion of the reproducibility crisis in science, any efforts to reduce batch-to-batch variability are more than welcome. One company with a plan to help in this area is “Absolute Antibody”, who believe that recombinant antibodies are the way forward. To learn more about making antibodies with recombinant technology, we spoke to Ian Wilkinson, PhD, Chief Scientific Officer.
Industry Insight
Bringing Balance to the Lab
It is an undeniable fact that the success of most experiments in R&D and analytical labs hinges on reliable weighing. It should go without say that dependable lab balances are critical. Often little focus is given to such a vital cog in the machine.
Industry Insight
Entering the Antibody Lottery: Tips for Avoiding Dubious Sources
Having reliable antibodies can make or break your assay. However, sourcing the right antibody for the job can sometimes feel like you’re entering the lottery: there are so many on the market, and often they just don’t live up to what was promised. To learn more about antibody validation and its importance, we got in touch with Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology.
Industry Insight
Talking Genes, Exercise and Nutrition With DNAFit
DNAfit is a personalized health and wellness company that offers an array of nutritional profiling services based on genetic science and technology. We spoke with Avi Lasarow, CEO and founder of DNAFit, to learn more about why it is important to look at our genetics in relation to diet and exercise choices, and what research currently exists in the field.
Industry Insight
How Might Data-centric Software Solutions Impact Analytical Chemistry Labs?
At the heart of most analytical chemistry analyses are data, the essential unit of measuring and monitoring not only your test subject but the analytical equipment itself. We spoke to Shawn Anderson, Senior Director of Marketing, Software and Informatics Division at Agilent about the move to data-centric software solutions and what the future may hold.
Advertisement